.png
)
Published on: 16th April, 2025 The Central Drugs Standard Control Organization (CDSCO) has released a crucial directive dated 11th April, 2025, addressing the unauthorized manufacture and marketing of Fixed Dose Combinations (FDCs) by pharmaceutical manufacturers in India. The notification highlights…
5th March, 2025 The Ministry of Health and Family Welfare, Government of India, has taken a significant step to streamline and enhance the registration process for Clinical Research Organizations (CRO) by mandating online registration through the SUGAM portal. This initiative,…
27th February, 2025 In a major step towards making essential medicines more affordable, the National Pharmaceutical Pricing Authority (NPPA) has directed pharmaceutical manufacturers and marketers to reduce the Maximum Retail Price (MRP) of specific drugs that recently received customs duty…
26 February, 2025 The Central Drugs Standard Control Organization (CDSCO) has issued a circular dated 24.02.2025 for all the manufacturers of Category D Fixed Dose Combinations (FDCs). CDSCO has previously provided two separate pathways for the approvals of Category D…
25th February,2025 The pharmaceutical industry operates under strict regulations to ensure the safety, efficacy, and quality of drugs available in the market. One of the critical aspects of drug classification in India is the definition of a "New Drug" under…